Human endogenous retrovirus regulates the initiation and progression of cancers (Review)
- Authors:
- Srishti Sahu
- Bharat Singh
- Ambak Kumar Rai
-
Affiliations: Department of Biotechnology, Motilal Nehru National Institute of Technology Allahabad, Prayagraj, Uttar Pradesh 211004, India - Published online on: August 3, 2022 https://doi.org/10.3892/mco.2022.2576
- Article Number: 143
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Wang X, Huang J and Zhu F: Human endogenous retroviral envelope protein syncytin-1 and inflammatory abnormalities in neuropsychological diseases. Front Psychiatry. 9(422)2018.PubMed/NCBI View Article : Google Scholar | |
|
Gao Y, Yu XF and Chen T: Human endogenous retroviruses in cancer: Expression, regulation and function. Oncol Lett. 21(121)2021.PubMed/NCBI View Article : Google Scholar | |
|
Grandi N and Tramontano E: HERV envelope proteins: physiological role and pathogenic potential in cancer and autoimmunity. Front Microbiol. 9(462)2018.PubMed/NCBI View Article : Google Scholar | |
|
Durnaoglu S, Lee SK and Ahnn J: Syncytin, envelope protein of human endogenous retrovirus (HERV): No longer ‘fossil’in human genome. Anim Cells Syst (Seoul). 25:358–368. 2022.PubMed/NCBI View Article : Google Scholar | |
|
Salavatiha Z, Soleimani-Jelodar R and Jalilvand S: The role of endogenous retroviruses-K in human cancer. Rev Med Virol. 30:1–13. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Santoni FA, Guerra J and Luban J: HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency. Retrovirology. 9(111)2012.PubMed/NCBI View Article : Google Scholar | |
|
Mi S, Lee X, Li X, Veldman GM, Finnerty H, Racie L, LaVallie E, Tang XY, Edouard P, Howes S, et al: Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature. 403:785–789. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Alcazer V, Bonaventura P and Depil S: Human endogenous retroviruses (HERVs): Shaping the innate immune response in cancers. Cancers (Basel). 12(610)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kim HS: Genomic impact, chromosomal distribution and transcriptional regulation of HERV elements. Mol Cells. 33:539–544. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Kremer D, Gruchot J, Weyers V, Oldemeier L, Göttle P, Healy L, Ho Jang J, Kang T, Xu Y, Volsko C, et al: pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proc Natl Acad Sci USA. 116:15216–15225. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Dervan E, Bhattacharyya DD, McAuliffe JD, Khan FH and Glynn SA: Ancient adversary-HERV-K (HML-2) in cancer. Front Oncol. 11(658489)2021.PubMed/NCBI View Article : Google Scholar | |
|
Huang WJ, Liu ZC, Wei W, Wang GH, Wu JG and Zhu F: Human endogenous retroviral pol RNA and protein detected and identified in the blood of individuals with schizophrenia. Schizophr Res. 83:193–199. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Monde K, Terasawa H, Nakano Y, Soheilian F, Nagashima K, Maeda Y and Ono A: Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity. Retrovirology. 14(27)2017.PubMed/NCBI View Article : Google Scholar | |
|
Liu X, Liu Z, Sun L, Ren J, Wu Z, Jiang X, Ji Q, Wang Q, Fan Y, Cai Y, et al: Resurrection of human endogenous retroviruses during aging reinforces senescence. bioRxiv: 2021.02.22.432260, 2021. | |
|
Levet S, Charvet B, Bertin A, Deschaumes A, Perron H and Hober D: Human endogenous retroviruses and type 1 diabetes. Curr Diab Rep. 19(141)2019.PubMed/NCBI View Article : Google Scholar | |
|
Hurst TP and Magiorkinis G: Activation of the innate immune response by endogenous retroviruses. J Gen Virol. 96:1207–1218. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Smith CC, Beckermann KE, Bortone DS, De Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, et al: Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. J Clin Invest. 128:4804–4820. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Mangeney M, Pothlichet J, Renard M, Ducos B and Heidmann T: Endogenous retrovirus expression is required for murine melanoma tumor growth in vivo. Cancer Res. 65:2588–2591. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Díaz-Carballo D, Acikelli AH, Klein J, Jastrow H, Dammann P, Wyganowski T, Guemues C, Gustmann S, Bardenheuer W, Malak S, et al: Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements. J Exp Clin Cancer Res. 34(81)2015.PubMed/NCBI View Article : Google Scholar | |
|
Müller MD, Holst PJ and Nielsen KN: A systematic review of expression and immunogenicity of human endogenous retroviral proteins in cancer and discussion of therapeutic approaches. Int J Mol Sci. 23(1330)2022.PubMed/NCBI View Article : Google Scholar | |
|
Liu CH, Grandi N, Palanivelu L, Tramontano E and Lin LT: Contribution of human retroviruses to disease development-A focus on the HIV- and HERV-cancer relationships and treatment strategies. Viruses. 12(852)2020.PubMed/NCBI View Article : Google Scholar | |
|
Kassiotis G: Endogenous retroviruses and the development of cancer. J Immunol. 192:1343–1349. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Subramanian RP, Wildschutte JH, Russo C and Coffin JM: Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology. 8(90)2011.PubMed/NCBI View Article : Google Scholar | |
|
Curty G, Marston JL, de Mulder Rougvie M, Leal FE, Nixon DF and Soares MA: Human endogenous retrovirus K in cancer: A potential biomarker and immunotherapeutic target. Viruses. 12(726)2020.PubMed/NCBI View Article : Google Scholar | |
|
Lavie L, Kitova M, Maldener E, Meese E and Mayer J: CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol. 79:876–883. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Contreras-Galindo R, López P, Vélez R and Yamamura Y: HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res Hum Retroviruses. 23:116–122. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Dai L, Del Valle L, Miley W, Whitby D, Ochoa AC, Flemington EK and Qin Z: Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. Oncogene. 37:4534–4545. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Sutkowski N, Conrad B, Thorley-Lawson DA and Huber BT: Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity. 15:579–589. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Toufaily C, Landry S, Leib-Mosch C, Rassart E and Barbeau B: Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Viruses. 3:2146–2159. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Romanish MT, Cohen CJ and Mager DL: Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. In: Seminars in cancer biology. Elsevier, pp246-253, 2010. | |
|
Conti A, Rota F, Ragni E, Favero C, Motta V, Lazzari L, Bollati V, Fustinoni S and Dieci G: Hydroquinone induces DNA hypomethylation-independent overexpression of retroelements in human leukemia and hematopoietic stem cells. Biochem Biophys Res Commun. 474:691–695. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Johnston JB, Silva C, Holden J, Warren KG, Clark AW and Power C: Monocyte activation and differentiation augment human endogenous retrovirus expression: Implications for inflammatory brain diseases. Ann Neurol. 50:434–442. 2001.PubMed/NCBI View Article : Google Scholar | |
|
Kelleher CA, Wilkinson DA, Freeman JD, Mager DL and Gelfand EW: Expression of novel transposon-containing mRNAs in human T cells. J Gen Virol. 77:1101–1110. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Karimi A, Sheervalilou R and Kahroba H: A new insight on activation of human endogenous retroviruses (HERVs) in malignant melanoma upon exposure to CuSO4. Biol Trace Elem Res. 191:70–74. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Lee JR, Ahn K, Kim YJ, Jung YD and Kim HS: Radiation-induced human endogenous retrovirus (HERV)-R env gene expression by epigenetic control. Radiat Res. 178:379–384. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Reiche J, Pauli G and Ellerbrok H: Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 20:435–440. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Katsumata K, Ikeda H, Sato M, Ishizu A, Kawarada Y, Kato H, Wakisaka A, Koike T and Yoshiki T: Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin Immunol. 93:75–80. 1999.PubMed/NCBI View Article : Google Scholar | |
|
Montesion M, Bhardwaj N, Williams ZH, Kuperwasser C and Coffin JM: Mechanisms of HERV-K (HML-2) transcription during human mammary epithelial cell transformation. J Virol. 92:e01258–17. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Barth M, Gröger V, Cynis H and Staege MS: Identification of human endogenous retrovirus transcripts in Hodgkin lymphoma cells. Mol Biol Rep. 46:1885–1893. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Liang Q, Xu Z, Xu R, Wu L and Zheng S: Expression patterns of non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in colon cancer. PLoS One. 7(e29950)2012.PubMed/NCBI View Article : Google Scholar | |
|
Zhou F, Li M, Wei Y, Lin K, Lu Y, Shen J, Johanning GL and Wang-Johanning F: Activation of HERV-K Env protein is essential for tumorigenesis and metastasis of breast cancer cells. Oncotarget. 7:84093–84117. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Chan SM, Sapir T, Park SS, Rual JF, Contreras-Galindo R, Reiner O and Markovitz DM: The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells. PLoS One. 14(e0212970)2019.PubMed/NCBI View Article : Google Scholar | |
|
Sauter M, Roemer K, Best B, Afting M, Schommer S, Seitz G, Hartmann M and Mueller-Lantzsch N: Specificity of antibodies directed against Env protein of human endogenous retroviruses in patients with germ cell tumors. Cancer Res. 56:4362–4365. 1996.PubMed/NCBI | |
|
Ibba G, Piu C, Uleri E, Serra C and Dolei A: Disruption by SaCas9 endonuclease of HERV-Kenv, a retroviral gene with oncogenic and neuropathogenic potential, inhibits molecules involved in cancer and amyotrophic lateral sclerosis. Viruses. 10(412)2018.PubMed/NCBI View Article : Google Scholar | |
|
Rycaj K, Plummer JB, Yin B, Li M, Garza J, Radvanyi L, Ramondetta LM, Lin K, Johanning GL, Tang DG and Wang-Johanning F: Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells. Clin Cancer Res. 21:471–483. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Zare M, Mostafaei S, Ahmadi A, Azimzadeh Jamalkandi S, Abedini A, Esfahani-Monfared Z, Dorostkar R and Saadati M: Human endogenous retrovirus env genes: Potential blood biomarkers in lung cancer. Microb Pathog. 115:189–193. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Krishnamurthy J, Rabinovich BA, Mi T, Switzer KC, Olivares S, Maiti SN, Plummer JB, Singh H, Kumaresan PR, Huls HM, et al: Genetic engineering of T cells to target HERV-K, an ancient retrovirus on melanoma. Clin Cancer Res. 21:3241–3251. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kreimer U, Schulz WA, Koch A, Niegisch G and Goering W: HERV-K and LINE-1 DNA methylation and reexpression in urothelial carcinoma. Front Oncol. 3(255)2013.PubMed/NCBI View Article : Google Scholar | |
|
Grabski DF, Hu Y, Sharma M and Rasmussen SK: Close to the bedside: A systematic review of endogenous retroviruses and their impact in oncology. J Surg Res. 240:145–155. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Giebler M, Staege MS, Blauschmidt S, Ohm LI, Kraus M, Würl P, Taubert H and Greither T: Elevated HERV-K expression in soft tissue sarcoma is associated with worsened relapse-free survival. Front Microbiol. 9(211)2018.PubMed/NCBI View Article : Google Scholar | |
|
Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K and Mueller-Lantzsch N: Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene. 24:3223–3228. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Aagaard L, Bjerregaard B, Kjeldbjerg AL, Pedersen FS, Larsson LI and Rossi JJ: Silencing of endogenous envelope genes in human choriocarcinoma cells shows that envPb1 is involved in heterotypic cell fusions. J Gen Virol. 93(1696)2012.PubMed/NCBI View Article : Google Scholar | |
|
Bergallo M, Montanari P, Mareschi K, Merlino C, Berger M, Bini I, Daprà V, Galliano I and Fagioli F: Expression of the pol gene of human endogenous retroviruses HERV-K and -W in leukemia patients. Arch Virol. 162:3639–3644. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Mangeney M, Renard M, Schlecht-Louf G, Bouallaga I, Heidmann O, Letzelter C, Richaud A, Ducos B and Heidmann T: Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA. 104:20534–20539. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Cianciolo GJ, Copeland TD, Oroszlan S and Snyderman R: Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science. 230:453–455. 1985.PubMed/NCBI View Article : Google Scholar | |
|
Lemaître C, Tsang J, Bireau C, Heidmann T and Dewannieux M: A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion. PLoS Pathog. 13(e1006451)2017.PubMed/NCBI View Article : Google Scholar | |
|
Bjerregaard B, Holck S, Christensen I and Larsson LI: Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci. 63:1906–1911. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Argaw-Denboba A, Balestrieri E, Serafino A, Cipriani C, Bucci I, Sorrentino R, Sciamanna I, Gambacurta A, Sinibaldi-Vallebona P and Matteucci C: HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features. J Exp Clin Cancer Res. 36(20)2017.PubMed/NCBI View Article : Google Scholar | |
|
Chen T, Meng Z, Gan Y, Wang X, Xu F, Gu Y, Xu X, Tang J, Zhou H, Zhang X, et al: The viral oncogene Np9 acts as a critical molecular switch for co-activating β-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia. 27:1469–1478. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Li M, Radvanyi L, Yin B, Rycaj K, Li J, Chivukula R, Lin K, Lu Y, Shen J, Chang DZ, et al: Downregulation of human endogenous retrovirus type K (HERV-K) viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clin Cancer Res. 23:5892–5911. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Zhang M, Liang JQ and Zheng S: Expressional activation and functional roles of human endogenous retroviruses in cancers. Rev Med Virol. 29(e2025)2019.PubMed/NCBI View Article : Google Scholar | |
|
Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, et al: Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer. Oncogene. 30:4697–4706. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Rai AK, Singh A, Saxena A, Seth T, Raina V and Mitra DK: Exonal switch down-regulates the expression of CD5 on blasts of acute T cell leukaemia. Clin Exp Immunol. 190:340–350. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Denne M, Sauter M, Armbruester V, Licht JD, Roemer K and Mueller-Lantzsch N: Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J Virol. 81:5607–5616. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Strissel PL, Ruebner M, Thiel F, Wachter D, Ekici AB, Wolf F, Thieme F, Ruprecht K, Beckmann MW and Strick R: Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets. Oncotarget. 3:1204–1219. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yu H, Liu T, Zhao Z, Chen Y, Zeng J, Liu S and Zhu F: Mutations in 3'-long terminal repeat of HERV-W family in chromosome 7 upregulate syncytin-1 expression in urothelial cell carcinoma of the bladder through interacting with c-Myb. Oncogene. 33:3947–3958. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Li S, Liu ZC, Yin SJ, Chen YT, Yu HL, Zeng J, Zhang Q and Zhu F: Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB. Neuroscience. 247:164–174. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Barbalat R, Ewald SE, Mouchess ML and Barton GM: Nucleic acid recognition by the innate immune system. Annu Rev Immunol. 29:185–214. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Bannert N, Hofmann H, Block A and Hohn O: HERVs new role in cancer: From accused perpetrators to cheerful protectors. Front Microbiol. 9(178)2018.PubMed/NCBI View Article : Google Scholar | |
|
Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, et al: Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. JCI Insight. 3(e121522)2018.PubMed/NCBI View Article : Google Scholar | |
|
Cao W, Kang R, Xiang Y and Hong J: Human endogenous retroviruses in clear cell renal cell carcinoma: Biological functions and clinical values. Onco Targets Ther. 13:7877–7885. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Rolland A, Jouvin-Marche E, Viret C, Faure M, Perron H and Marche PN: The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol. 176:7636–7644. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S and Johanning GL: Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer. Int J Cancer. 134:587–595. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Mueller T, Hantsch C, Volkmer I and Staege MS: Differentiation-dependent regulation of human endogenous retrovirus K sequences and neighboring genes in germ cell tumor cells. Front Microbiol. 9(1253)2018.PubMed/NCBI View Article : Google Scholar | |
|
Kleiman A, Senyuta N, Tryakin A, Sauter M, Karseladze A, Tjulandin S, Gurtsevitch V and Mueller-Lantzsch N: HERV-K(HML-2) GAG/ENV antibodies as indicator for therapy effect in patients with germ cell tumors. Int J Cancer. 110:459–461. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Götzinger N, Sauter M, Roemer K and Mueller-Lantzsch N: Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. J Gen Virol. 77:2983–2990. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Wang Z, Zheng Y, Park HJ, Li J, Carr JR, Chen YJ, Kiefer MM, Kopanja D, Bagchi S, Tyner AL and Raychaudhuri P: Targeting FoxM1 effectively retards p53-null lymphoma and sarcoma. Mol Cancer Ther. 12:759–767. 2013.PubMed/NCBI View Article : Google Scholar | |
|
von Lintig FC, Dreilinger AD, Varki NM, Wallace AM, Casteel DE and Boss GR: Ras activation in human breast cancer. Breast Cancer Res Treat. 62:51–62. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I and Tsarfaty I: Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker. Neoplasia. 10:521–533. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Johanning GL, Malouf GG, Zheng X, Esteva FJ, Weinstein JN, Wang-Johanning F and Su X: Expression of human endogenous retrovirus-K is strongly associated with the basal-like breast cancer phenotype. Sci Rep. 7(41960)2017.PubMed/NCBI View Article : Google Scholar | |
|
Kim HJ, Moon BI, Lee JW, Kim SC and Kim HJ: Age-related reduction of antibody response against the human endogenous retrovirus K envelope in women. Oncotarget. 7:17327–17337. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ and Wang-Johanning F: Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology. 4(e1047582)2015.PubMed/NCBI View Article : Google Scholar | |
|
Jin X, Xu XE, Jiang YZ, Liu YR, Sun W, Guo YJ, Ren YX, Zuo WJ, Hu X, Huang SL, et al: The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation. Sci Adv. 5(eaat9820)2019.PubMed/NCBI View Article : Google Scholar | |
|
Li N, Li Y, Lv J, Zheng X, Wen H, Shen H, Zhu G, Chen TY, Dhar SS, Kan PY, et al: ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes. Mol Cell. 63:470–484. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Büscher K, Hahn S, Hofmann M, Trefzer U, Ozel M, Sterry W, Löwer J, Löwer R, Kurth R and Denner J: Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 16:223–234. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, Löwer J and Löwer R: Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses. 24:717–723. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Kudo-Saito C, Yura M, Yamamoto R and Kawakami Y: Induction of immunoregulatory CD271+ cells by metastatic tumor cells that express human endogenous retrovirus H. Cancer Res. 74:1361–1370. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Maliniemi P, Vincendeau M, Mayer J, Frank O, Hahtola S, Karenko L, Carlsson E, Mallet F, Seifarth W, Leib-Mösch C and Ranki A: Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma. PLoS One. 8(e76281)2013.PubMed/NCBI View Article : Google Scholar | |
|
Blond JL, Lavillette D, Cheynet V, Bouton O, Oriol G, Chapel-Fernandes S, Mandrand B, Mallet F and Cosset FL: An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol. 74:3321–3329. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Wallace TA, Downey RF, Seufert CJ, Schetter A, Dorsey TH, Johnson CA, Goldman R, Loffredo CA, Yan P, Sullivan FJ, et al: Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers. Carcinogenesis. 35:2074–2083. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Reis BS, Jungbluth AA, Frosina D, Holz M, Ritter E, Nakayama E, Ishida T, Obata Y, Carver B, Scher H, et al: Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein. Clin Cancer Res. 19:6112–6125. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Saini SK, Ørskov AD, Bjerregaard AM, Unnikrishnan A, Holmberg-Thydén S, Borch A, Jensen KV, Anande G, Bentzen AK, Marquard AM, et al: Human endogenous retroviruses form a reservoir of T cell targets in hematological cancers. Nat Commun. 11(5660)2020.PubMed/NCBI View Article : Google Scholar | |
|
Alqahtani S, Promtong P, Oliver AW, He XT, Walker TD, Povey A, Hampson L and Hampson IN: Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines. Mutagenesis. 31:695–702. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Sun Y, Ouyang DY, Pang W, Tu YQ, Li YY, Shen XM, Tam SC, Yang HY and Zheng YT: Expression of syncytin in leukemia and lymphoma cells. Leuk Res. 34:1195–1202. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD and Markovitz DM: Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol. 82:9329–9336. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Tatkiewicz W, Dickie J, Bedford F, Jones A, Atkin M, Kiernan M, Maze EA, Agit B, Farnham G, Kanapin A and Belshaw R: Characterising a human endogenous retrovirus (HERV)-derived tumour-associated antigen: Enriched RNA-Seq analysis of HERV-K(HML-2) in mantle cell lymphoma cell lines. Mob DNA. 11(9)2020.PubMed/NCBI View Article : Google Scholar | |
|
Morgan D and Brodsky I: Human endogenous retrovirus (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp Hematol. 32:520–525. 2004.PubMed/NCBI View Article : Google Scholar | |
|
Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, et al: Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells. J Clin Invest. 118:1099–1109. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Rao S, Abdul T, Kurlander R, Harashima N, Lundqvist A, Hong J, Malinzak E, Smith A, Cherkasova E, McCoy P, et al: The human endogenous retrovirus (HERV) derived kidney cancer antigen CT-RCC1 induces proliferation of CD8+ antigen-specific T-cells in vitro that kill renal cell carcinoma (RCC) and is up-regulated by inhibiting histone deacetylase. Cancer Res. 68 (9 Suppl)(S1033)2008. | |
|
Haruta M, Gray WM and Sussman MR: Regulation of the plasma membrane proton pump (H(+)-ATPase) by phosphorylation. Curr Opin Plant Biol. 28:68–75. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Weyerer V, Strissel PL, Stöhr C, Eckstein M, Wach S, Taubert H, Brandl L, Geppert CI, Wullich B, Cynis H, et al: Endogenous retroviral-K envelope is a novel tumor antigen and prognostic indicator of renal cell carcinoma. Front Oncol. 11(657187)2021.PubMed/NCBI View Article : Google Scholar | |
|
Gabaev I, Williamson JC, Crozier TWM, Schulz TF and Lehner PJ: Quantitative proteomics analysis of lytic KSHV infection in human endothelial cells reveals targets of viral immune modulation. Cell Rep. 33(108249)2020.PubMed/NCBI View Article : Google Scholar | |
|
Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, Hein A, Rote NS, Cope LM, Snyder A, et al: Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell. 162:974–986. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Larsen JM, Christensen IJ, Nielsen HJ, Hansen U, Bjerregaard B, Talts JF and Larsson LI: Syncytin immunoreactivity in colorectal cancer: Potential prognostic impact. Cancer Lett. 280:44–49. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Golkaram M, Salmans ML, Kaplan S, Vijayaraghavan R, Martins M, Khan N, Garbutt C, Wise A, Yao J, Casimiro S, et al: HERVs establish a distinct molecular subtype in stage II/III colorectal cancer with poor outcome. NPJ Genom Med. 6(13)2021.PubMed/NCBI View Article : Google Scholar |
